Future Drug Targets in Periodontal Personalised Medicine-A Narrative Review
Periodontal disease is an infection-driven inflammatory disease characterized by the destruction of tooth-supporting tissues. The establishment of chronic inflammation will result in progressive destruction of bone and soft tissue changes. Severe periodontitis can lead to tooth loss. The disease has complex pathogenesis with an interplay between genetic, environmental, and host factors and pathogens. Effective management consists of plaque control and non-surgical interventions, along with adjuvant strategies to control inflammation and disrupt the pathogenic subgingival biofilms. Recent studies have examined novel approaches for managing periodontal diseases such as modulating microbial signaling mechanisms, tissue engineering, and molecular targeting of host inflammatory substances. Mounting evidence suggests the need to integrate omics-based approaches with traditional therapy to address the disease. This article discusses the various evolving and future drug targets, including proteomics, gene therapeutics, vaccines, and nanotechnology in personalized periodontal medicine for the effective management of periodontal diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Journal of personalized medicine - 12(2022), 3 vom: 28. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yadalam, Pradeep Kumar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Drug targets |
|---|
| Anmerkungen: |
Date Revised 29.03.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/jpm12030371 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338606602 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338606602 | ||
| 003 | DE-627 | ||
| 005 | 20231226001042.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jpm12030371 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1128.xml |
| 035 | |a (DE-627)NLM338606602 | ||
| 035 | |a (NLM)35330371 | ||
| 035 | |a (PII)371 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yadalam, Pradeep Kumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Future Drug Targets in Periodontal Personalised Medicine-A Narrative Review |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.03.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Periodontal disease is an infection-driven inflammatory disease characterized by the destruction of tooth-supporting tissues. The establishment of chronic inflammation will result in progressive destruction of bone and soft tissue changes. Severe periodontitis can lead to tooth loss. The disease has complex pathogenesis with an interplay between genetic, environmental, and host factors and pathogens. Effective management consists of plaque control and non-surgical interventions, along with adjuvant strategies to control inflammation and disrupt the pathogenic subgingival biofilms. Recent studies have examined novel approaches for managing periodontal diseases such as modulating microbial signaling mechanisms, tissue engineering, and molecular targeting of host inflammatory substances. Mounting evidence suggests the need to integrate omics-based approaches with traditional therapy to address the disease. This article discusses the various evolving and future drug targets, including proteomics, gene therapeutics, vaccines, and nanotechnology in personalized periodontal medicine for the effective management of periodontal diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a drug targets | |
| 650 | 4 | |a gene therapy | |
| 650 | 4 | |a host modulation | |
| 650 | 4 | |a nanotechnology | |
| 650 | 4 | |a periodontal diseases | |
| 650 | 4 | |a personalized medicine | |
| 650 | 4 | |a proteomics | |
| 650 | 4 | |a vaccines | |
| 700 | 1 | |a Kalaivani, V |e verfasserin |4 aut | |
| 700 | 1 | |a Fageeh, Hammam Ibrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Ibraheem, Wael |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Ahmari, Manea Musa |e verfasserin |4 aut | |
| 700 | 1 | |a Khan, Samar Saeed |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmed, Zeeshan Heera |e verfasserin |4 aut | |
| 700 | 1 | |a Abdulkarim, Hesham H |e verfasserin |4 aut | |
| 700 | 1 | |a Baeshen, Hosam Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Balaji, Thodur Madapusi |e verfasserin |4 aut | |
| 700 | 1 | |a Bhandi, Shilpa |e verfasserin |4 aut | |
| 700 | 1 | |a Raj, A Thirumal |e verfasserin |4 aut | |
| 700 | 1 | |a Patil, Shankargouda |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of personalized medicine |d 2011 |g 12(2022), 3 vom: 28. Feb. |w (DE-627)NLM228113881 |x 2075-4426 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g number:3 |g day:28 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/jpm12030371 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2022 |e 3 |b 28 |c 02 | ||